Pharmaceuticals, Biotechnology and Life Sciences
As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug.…
LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep,…
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for…
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor…
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…
Seasoned life sciences legal executive brings extensive public company experience, including broad strategic and financial transaction expertiseSAN DIEGO, Aug. 26,…
EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) — NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its…
PURCHASE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company…
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that…